Expression of IL-24 and IL-24 receptors in human wound tissues and the biological implications of IL-24 on keratinocytes

Wound Repair and Regeneration

Volumn 20, Issue 6, 2012, Pages 896-903

  Bosanquet, David C ^a   Harding, Keith G ^a   Ruge, Fiona ^a   Sanders, Andrew J ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 24; PROTEIN KINASE B INHIBITOR; SMAD3 PROTEIN;

ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CELL ADHESION; CELL MIGRATION; DRUG EFFECT; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WOUND HEALING;

ACUTE DISEASE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; GENE EXPRESSION; HUMANS; INTERLEUKINS; KERATINOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84868542644     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00840.x     Document Type: Article

References (39)

1. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB,. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-2486.
2. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB,. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA 1996; 93: 9160-9165.
3. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su ZZ, Lebedeva IV, Kang DC, Jiang HP, Lin JJ, Alexandre D, Chen YM, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB,. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 2001; 20: 7051-7063.
4. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG,. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011; 29: 71-109.
5. Wang M, Tan ZJ, Zhang R, Kotenko SV, Liang P,. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 2002; 277: 7341-7347.
6. Wang M, Liang P,. Interleukin-24 and its receptors. Immunology 2005; 114: 166-170.
7. Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H,. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukocyte Biol 2004; 76: 314-321.
8. Langer JA, Cutrone EC, Kotenko S,. The class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 2004; 15: 33-48.
9. Pestka S, Krause CD, Sarkar D, Walter MR, Shi YF, Fisher PB,. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929-979.
10. Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D,. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 2005; 174: 2990-2999.
11. Emdad L, Lebedeva IV, Su ZZ, Gupta P, Sauane M, Dash R, Grant S, Dent P, Curiel DT, Sarkar D, Fisher PB,. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol Ther 2009; 8: 402-411.
12. Fisher PB,. Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 2005; 65: 10128-10138.
13. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT, Dent P, Fisher PB,. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol Ther 2006; 111: 596-628.
14. Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, Staudt MR, Liu SJ, Taher MM, Xiao R, Barral P, Lee SG, Wang D, Vozhilla N, Park ES, Chatman L, Boukerche H, Ramesh R, Inoue S, Chada S, Li R, De Pass AL, Mahasreshti PJ, Dmitriev IP, Curiel DT, Yacoub A, Grant S, Dent P, Senzer N, Nemunaitis JJ, Fisher PB,. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol 2007; 31: 985-1007.
15. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, Hood JV, Merritt J, Chada S,. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 2005; 11: 160-172.
16. Kunz S, Wolk K, Witte E, Witte K, Doecke WD, Volk HD, Sterry W, Asadullah K, Sabat R,. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006; 15: 991-1004.
17. Seifert M, Gruenberg BH, Sabat R, Donner P, Gruetz G, Volk HD, Wolk K, Asadullah K,. Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expression. Exp Dermatol 2003; 12: 137-144.
18. Poindexter NJ, Williams RR, Powis G, Jen E, Caudle AS, Chada S, Grimm EA,. IL-24 is expressed during wound repair and inhibits TGF alpha-induced migration and proliferation of keratinocytes. Exp Dermatol 2010; 19: 714-722.
19. Kreis S, Philippidou D, Margue C, Rolvering C, Haan C, Dumoutier L, Renauld JC, Behrmann I,. Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS ONE 2007; 2: e1300.
20. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE,. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771.
21. Conway K, Ruge F, Price P, Harding KG, Jiang WG,. Hepatocyte growth factor regulation: an integral part of why wounds become chronic. Wound Repair Regen 2007; 15: 683-692.
22. Sanders AJ, Jiang DG, Jiang WG, Harding KG, Patel GK,. Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration. Int Wound J 2011; 8: 500-507.
23. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF, Puntis MCA,. Inhibition of hepatocyte growth factor-induced motility and in-vitro invasion of human colon-cancer cells by gamma-linolenic acid. Br J Cancer 1995; 71: 744-752.
24. Parr C, Watkins G, Mansel RE, Jiang WG,. The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 2004; 10: 202-211.
25. Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L, Mansel RE,. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer 2008; 7: 71.
26. Martin P,. Wound healingâaiming for perfect skin regeneration. Science 1997; 276: 75-81.
27. Suzuki K, Saito J, Yanai R, Yamada N, Chikama T, Seki K, Nishida T,. Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res 2003; 22: 113-133.
28. Kanchanawong P, Shtengel G, Pasapera AM, Ramko EB, Davidson MW, Hess HF, Waterman CM,. Nanoscale architecture of integrin-based cell adhesions. Nature 2010; 468: 580-584.
29. Mhashilkar AM, Schrock RD, Hindi M, Liao J, Sieger K, Kourouma F, Zou-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R, Chada S,. Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med 2001; 7: 271-282.
30. Levayer R, Lecuit T,. Breaking down EMT. Nat Cell Biol 2008; 10: 757-759.
31. Yan C, Grimm WA, Garner WL, Qin L, Travis T, Tan N, Han YP,. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am J Pathol 2010; 176: 2247-2258.
32. Pedersen TX, Leethanakul C, Patel V, Mitola D, Lund LR, Dano K, Johnsen M, Gutkind JS, Bugge TH,. Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma. Oncogene 2003; 22: 3964-3976.
33. Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R,. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 2004; 4: 577-592.
34. Mhashilkar AM, Stewart AL, Sieger K, Yang HY, Khimani AH, Ito I, Saito Y, Hunt KK, Grimm EA, Roth JA, Meyn RE, Ramesh R, Chada S,. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol Ther 2003; 8: 207-219.
35. Fresno Vara JA, Casado E, de, Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M,. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 2004; 30: 193-204.
36. Paez J, Sellers WR,. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 2003; 115: 145-167.
37. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW,. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428: 332-337.
38. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C,. PI3K/Akt and apoptosis: size matters. Oncogene 2003; 22: 8983-8998.
39. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van, Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L,. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63: 2172-2178.